Phase III Study of Irbersartan for the Early Treatment of Severe Sepsis Patients

Trial Profile

Phase III Study of Irbersartan for the Early Treatment of Severe Sepsis Patients

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Sepsis
  • Focus Therapeutic Use
  • Acronyms SartSep
  • Most Recent Events

    • 06 Jan 2017 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified 19 Nov 2013).
    • 30 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top